000			02079 a2200565 4500
005			20250513195351.0
264		0	_c20000201
008			200002s 0 0 eng d
022			_a0923-7534
024	7		_a10.1023/a:1008392528248 _2doi
040			_aNLM _beng _cNLM
100	1		_aJerkeman, M
245	0	0	_aCHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 1999
300			_a1079-86 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBleomycin _xadministration & dosage
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aQuality of Life
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
650	0	4	_aVincristine _xadministration & dosage
700	1		_aAnderson, H
700	1		_aCavallin-Ståhl, E
700	1		_aDictor, M
700	1		_aHagberg, H
700	1		_aJohnson, A
700	1		_aKaasa, S
700	1		_aKvaløy, S
700	1		_aSundström, C
700	1		_aAkerman, M
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 10 _gno. 9 _gp. 1079-86
856	4	0	_uhttps://doi.org/10.1023/a:1008392528248 _zAvailable from publisher's website
999			_c10528866 _d10528866